1535TiP - KEYNOTE-604: Phase 3 trial of pembrolizumab plus etoposide/platinum (EP) for first-line treatment of extensive stage small-cell lung cancer (ES-SCLC)

C.M Rudin,L Shen,M.C Pietanza

doi:10.1093/annonc/mdx386.008

1535TiP - KEYNOTE-604: Phase 3 trial of pembrolizumab plus etoposide/platinum (EP) for first-line treatment of extensive stage small-cell lung cancer (ES-SCLC)

C.M Rudin, L Shen + Show 1 more

Open Access

https://doi.org/10.1093/annonc/mdx386.008

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Sep 1, 2017
Citations: 6	License type: publisher-specific-oa

Affiliation: Memorial Sloan Kettering Cancer Center, MSD (United States)

#Extensive Stage Small-cell Lung Cancer #Trial Of Pembrolizumab + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

1535TiP - KEYNOTE-604: Phase 3 trial of pembrolizumab plus etoposide/platinum (EP) for first-line treatment of extensive stage small-cell lung cancer (ES-SCLC)

Full Text